This is rather intriguing as MEK inhibitors including trametinib is associated with acneiform dermatitis, owing to off-target effects on KLF4/NF-κB-dependent transcription of inflammatory cytokines (57). The gene discussed is MAP2K7; the disease is acneiform dermatitis.